Behzad Aghazadeh, Ph.D.

Behzad Aghazadeh, Ph.D.

DirectoratWhitehawk Therapeutics· In proxies 2023–2025

Behzad Aghazadeh, Ph.D. sits on 3 public boards.

Boards1

  • Whitehawk TherapeuticsDirector · 3 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Whitehawk TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -71%
  2. Scribe Therapeutics Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Immunomedics, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?